N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1 Purity>99.0% (HPLC) Afatinib Dimaleate Intermediate Factory

Tsanangudzo Pfupi:

Kemikari Zita: N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine

CAS: 162012-67-1

Kuchena:> 99.0% (HPLC)

Chitarisiko: Yero Yero kusvika Yero Upfu

Pakati peAfatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine
Mashoko anoreva zvakafanana N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitro-4-Quinazolinamine;(3-Chloro-4-Fluorophenyl)(7-Fluoro-6-Nitroquinazolin-4-yl)amine;4-(3-Chloro-4-Fluoroanilino)-7-Fluoro-6-Nitroquinazoline;Afatinib Intermediate A
Nhamba yeCAS 162012-67-1
Nhamba yeCAT RF-PI2026
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C14H7ClF2N4O2
Molecular Weight 336.68
Sensitivity Mhepo Inonzwa, Inonzwa Kupisa
Melting Point 242.0~244.0℃
Boiling Point 489℃
Density 1.616
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Yero Yero kusvika Yero Hupfu
Kuchena / Analysis Method >99.0% (HPLC)
Kurasika paKuomesa <0.50%
Residue paIgnition <0.20%
Related Substances
Kusachena Kwemunhu <0.50%
Zvose Zvisina Kuchena <1.00%
Heavy Metals ≤20ppm
Infrared Spectrum Inopindirana neChimiro
Proton NMR Spectrum Inopindirana neChimiro
Test Standard Enterprise Standard
Usage Pakati peAfatinib Dimaleate (CAS: 850140-73-7)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine (CAS: 162012-67-1) iri pakati pekugadzirisa kweAfatinib Dimaleate (CAS: 850140-73-7) .Afatinib Dimaleate imhando yemunyu yeAfatinib.Afatinib chizvarwa chechipiri, chinoshandiswa nemuromo, chisingachinjiki inhibitor yeErbB mhuri ye tyrosine kinases.Mechanism of ActionAfatinib inoderedza zviratidzo zveErbB kuburikidza nekubatana zvakasimba kune kinase domains ye epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2 uye HER4, zvichiita kuti inhibition isingagadziriswi ye tyrosine kinase autophosphorylation;iyo inodzivisawo transphosphorylation yeHER3.Afatinib inobvumirwa se monotherapy yekurapa kweEGFR tyrosine kinase inhibitor (TKI) -vasina ruzivo rwevanhu vakuru vane nzvimbo yepamusoro kana TsanangudzoChEBI: Munyu we maleate unowanikwa nekubatanidza afatinib nemhando mbiri dze molar dze maleic acid.Inoshandiswa pakurapa-mutsara wevarwere vane metastatic isiri-diki cell kenza yemapapu.

Nyora meseji yako pano uye titumire kwatiri